Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 01, 2019

SELL
$81.56 - $100.67 $795,291 - $981,633
-9,751 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$79.28 - $95.27 $801,520 - $963,179
-10,110 Reduced 50.9%
9,751 $834,000
Q3 2018

Nov 13, 2018

SELL
$83.5 - $93.23 $861,970 - $962,413
-10,323 Reduced 34.2%
19,861 $1.82 Million
Q2 2018

Aug 07, 2018

BUY
$79.9 - $89.2 $2.34 Million - $2.62 Million
29,324 Added 3409.77%
30,184 $2.57 Million
Q1 2018

May 14, 2018

BUY
$71.51 - $84.69 $61,498 - $72,833
860 New
860 $72,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Convergence Investment Partners, LLC Portfolio

Follow Convergence Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Investment Partners, LLC with notifications on news.